Linefsky, J. P., Mahaffey, K. W., Pieper, K. S., Lin, A., Reist, C. J., Antman, E., … Califf, R. M. (2006). Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial. CIRCULATION, 114(18), 421–421.

Linefsky, Jason P., Kenneth W. Mahaffey, Karen S. Pieper, Annie Lin, Craig J. Reist, Elliott Antman, Shaun G. Goodman, et al. “Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial.” CIRCULATION 114, no. 18 (October 31, 2006): 421–421.

Linefsky JP, Mahaffey KW, Pieper KS, Lin A, Reist CJ, Antman E, et al. Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial. CIRCULATION. 2006 Oct 31;114(18):421–421.

Linefsky, Jason P., et al. “Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial.” CIRCULATION, vol. 114, no. 18, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2006, pp. 421–421.

Linefsky JP, Mahaffey KW, Pieper KS, Lin A, Reist CJ, Antman E, Goodman SG, French JK, Roe MT, Harrington RA, Ferguson JJ, Califf RM. Differences between site-reported and core laboratory creatine kinase-MB values in an international clinical trial: Results from the SYNERGY trial. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2006 Oct 31;114(18):421–421.